GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (XTER:DMP) » Definitions » Pretax Margin %

Dermapharm Holding SE (XTER:DMP) Pretax Margin % : 15.02% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Dermapharm Holding SE's Pre-Tax Income for the three months ended in Sep. 2024 was €47 Mil. Dermapharm Holding SE's Revenue for the three months ended in Sep. 2024 was €312 Mil. Therefore, Dermapharm Holding SE's pretax margin for the quarter that ended in Sep. 2024 was 15.02%.

The historical rank and industry rank for Dermapharm Holding SE's Pretax Margin % or its related term are showing as below:

XTER:DMP' s Pretax Margin % Range Over the Past 10 Years
Min: 9.07   Med: 17   Max: 31.07
Current: 12.23


XTER:DMP's Pretax Margin % is ranked better than
67.24% of 995 companies
in the Drug Manufacturers industry
Industry Median: 5.23 vs XTER:DMP: 12.23

Dermapharm Holding SE Pretax Margin % Historical Data

The historical data trend for Dermapharm Holding SE's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Pretax Margin % Chart

Dermapharm Holding SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.70 15.78 31.07 21.11 9.34

Dermapharm Holding SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.24 1.60 21.38 9.57 15.02

Competitive Comparison of Dermapharm Holding SE's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Pretax Margin % falls into.



Dermapharm Holding SE Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Dermapharm Holding SE's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=105.997/1135.351
=9.34 %

Dermapharm Holding SE's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=46.8/311.602
=15.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dermapharm Holding SE  (XTER:DMP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Dermapharm Holding SE Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermapharm Holding SE Business Description

Traded in Other Exchanges
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts, and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing, and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals, and cosmetics products. Parallel import brands business operates under the AxiCorp brand.
Executives
Wilhelm Beier Supervisory Board
Dr. Hans-georg Feldmeier Board of Directors
Christof Dreibholz Board of Directors
Lothar Lanz Supervisory Board
Anja Schorn Board Member Themis Beteiligungs-AG
Hilde Neumeyer Board of Directors

Dermapharm Holding SE Headlines

No Headlines